Equities
  • Price (USD)55.51
  • Today's Change-1.22 / -2.15%
  • Shares traded34.66k
  • 1 Year change-13.16%
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024 20:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
LONN:SWX since
announced
Transaction
value
Genentech Inc-Biologics Manufacturing Facility,Vacaville,CaliforniaAnnounced20 Mar 202420 Mar 2024Announced3.86%1.20bn
Data delayed at least 15 minutes, as of Jun 10 2024 12:21 BST.

Institutional shareholders

0.60%Per cent of shares held by top holders
HolderShares% Held
SBI Funds Management Ltd.as of 31 May 20243.72m0.50%
Manning & Napier Advisors LLCas of 30 Apr 2024249.13k0.03%
Zevin Asset Management LLCas of 31 Mar 2024123.11k0.02%
Torray Investment Partners LLCas of 31 Mar 2024109.70k0.02%
Strategic Advisers LLCas of 31 Mar 202484.29k0.01%
Madison Asset Management LLCas of 31 Mar 202460.25k0.01%
Causeway Capital Management LLCas of 09 May 202452.22k0.01%
Invesco Advisers, Inc.as of 29 Feb 202444.28k0.01%
Domini Impact Investments LLCas of 31 Jan 202425.20k0.00%
RhumbLine Advisers LPas of 31 Mar 202413.86k0.00%
More ▼
Data from 31 Jan 2024 - 31 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.